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Abstract.  We have investigated a possible involvement 
of GTPases in nuclear protein import using an in vitro 
transport system involving digitonin-permeabilized 
cells supplemented with exogenous cytosol. Transport 
in this system was measured with a novel ELISA- 
based assay that allows rapid quantitative analysis. 
GTP~,S and other nonhydrolyzable analogues of GTP 
were found to rapidly inhibit the rate of in vitro nu- 
clear import.  Transport  inhibition by GTP3,S was de- 
pendent on the concentrations of permeabilized cells 
and cytosol, and was strongly enhanced by a cytosolic 
factor(s).  The predominant cytosolic component 
responsible for this inhibition was found in a 20-30- 
kD fraction in molecular sieving chromatography. 
Furthermore,  a component(s) of this 20-30-kD frac- 
tion was itself required for efficient nuclear import. 
Biochemical complementation with bacterially ex- 
pressed protein demonstrated that this essential 
GTP3,S-sensitive transport factor was Ran/TC4,  a pre- 
viously described GTPase of the Ras superfamily 
found in both nucleus and cytoplasm. Ran/TC4 and its 
guanine nucleotide release protein RCC1  have previ- 
ously been implicated in DNA replication,  cell cycle 
checkpoint control, and RNA synthesis, processing 
and export.  Our results suggest that Ran/TC4 serves to 
integrate nuclear protein import with these other nu- 
clear activities. 
M 
OLECULAR exchanges  between nucleus  and cyto- 
plasm occur continuously in eukaryotic cells and 
are fundamentally  important for cellular  metabo- 
lism. The boundary of the nucleus is formed by the nuclear 
envelope (NE) ~, a double membrane system that is continu- 
ous with the endoplasmic reticulum.  Transport  across the 
NE is carded out by elaborate supramolecular  structures 
called nuclear pore complexes (NPCs; reviewed by Nigg et 
al., 1991; Forbes, 1992; Gerace, 1992). The NPC has a mass 
of '~125  x  106 D (Reichelt et al.,  1990), but relatively few 
of  its  polypeptides  have  been  identified.  Nevertheless, 
general  transport properties of the NPC have been deter- 
mined by functional  studies.  The NPC contains  an aqueous 
channel(s)  with a diameter of *10 nm, which allows rapid, 
nonselective diffusion  of ions,  metabolites and other small 
molecules across the NE (Paine et al., 1975; Peters,  1986). 
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1. Abbreviations  used in this paper: ARE ADP-ribosylation  factor; B-BSA, 
biotinylated  BSA;  GAE  GTPase-activating  protein;  GNRE  guanine 
nucleotide  release  protein;  NE,  nuclear envelope;  NPC,  nuclear pore 
complex. 
Most proteins and RNAs are too large to diffuse through the 
NPC  at physiologically  significant  rates,  and  instead  are 
transported through  a gated channel  in the NPC by highly 
selective,  signal-mediated  mechanisms  (Nigg et al.,  1991; 
Forbes, 1992; Gerace,  1992). 
Signals  that  specify nuclear  protein  import  have  been 
characterized  in  detail,  and  usually  involve  short  basic 
stretches  of amino acids in the transported proteins called 
nuclear localization sequences (NLSs; reviewed by Dingwall 
and Laskey, 1991). A different signal is responsible for nu- 
clear  import  of small  nuclear  ribonucleoprotein  particles 
containing  certain  U  RNAs (U snRNPs)  (Fischer et al., 
1991; Michaud and Goldfarb,  1991), although  its precise 
molecular nature is unknown. Furthermore, signals involved 
in RNA and protein export from the nucleus are just begin- 
ning to be characterized  (Hamm and Mattaj, 1990; see also 
Schmidt-Zachmann  et al.,  1993). 
Recent work has  suggested  that  nuclear  import can be 
regulated in several different ways (Nigg et al.,  1991; Ger- 
ace, 1992). One type of mechanism affects the efficiency or 
availability of NLSs on individual proteins.  For example this 
mechanism controls the nuclear import of certain transcrip- 
tion factors and protein kinases  (Jans et al.,  1991; Nigg et 
al., 1991; Moll et al., 1991; Henkel et al.,  1992). A second 
type of mechanism  appears to affect the protein import ma- 
chinery rather than individual proteins (Feldherr and Akin, 
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important  for  control  of  gene  expression  and  cellular 
function. 
NLS-mediated nuclear protein import requires ATP and is 
inhibited at low temperatures (Newmeyer and Forbes, 1988; 
Richardson et al., 1988). An early step in nuclear import in- 
volves ligand "docking" at the cytoplasmic surface of the 
NPC,  which can occur in the absence of ATP and at 0°C 
(Newmeyer and Forbes,  1988; Richardson et al.,  1988).  A 
subsequent step involves ligand translocation to the nucleo- 
plasmic side of the NPC. The latter process involves channel 
gating (Feldherr et al., 1984),  which is both ATP and tem- 
perature dependent. The precise components that mediate 
these and other steps  of nuclear import are unknown. 
Several in vitro systems that yield physiologically relevant 
mediated  nuclear  import  have  been  developed  recently 
(Newmeyer et al., 1986; Adam et al., 1990), providing valu- 
able  approaches  for  analyzing transport  mechanisms.  A 
system  devised  in  our  laboratory  consists  of digitonin- 
permeabilized  cells  (which  retain  an  intact  NE)  sup- 
plemented with exogenous cytosol and ATP (Adam et al., 
1990).  Studies with this and other  systems have demon- 
strated a  requirement for multiple cytosolic factors in nu- 
clear import (Adam et al.,  1990;  Newmeyer and Forbes, 
1990; Moore and Blobel, 1992). One such factor is a protein 
that specifically binds NLSs with high affinity and has the 
properties  of a  functional import receptor  (Adam et al., 
1989; Adam and Gerace,  1991). Other cytosolic factors in- 
clude a component that interacts with O-linked glycoproteins 
of the NPC (Sterne-Marr et al., 1992), the ubiquitous cellu- 
lar protein hsc70 (Imamoto et al.,  1992;  Shi and Thomas, 
1992),  and  several  activities detected by fractionation of 
cytosol (Newmeyer and Forbes,  1990;  Moore and Blobel, 
1992). 
It is now evident that GTPases are regulators of a  vast 
diversity of cellular functions, including protein synthesis 
and translocation, signal transduction, and membrane trans- 
port (reviewed by Bourne et al., 1991; Pfeffer, 1992; Nuoffer 
and Balch, 1993). GTPases are molecular switches that exist 
in predominantly two conformations determined by the state 
of bound guanine nucleotide, an active form containing GTP 
and  an  inactive  form  containing  GDP.  The  activity  of 
GTPases is regulated by a combination of GTPase-activating 
proteins (GAPs), which stimulate the rate of GTP hydroly- 
sis, and guanine nucleotide release proteins (GNRPs), which 
catalyze the release of bound GDP and allow GTPases to re- 
bind GTP (Bourne et al.,  1991). 
We previously identified a small GTP-binding protein that 
is highly concentrated in the NE using photocross-linking 
approaches (Seydel and Gerace, 1991). In this study we have 
used  an  in  vitro  functional assay  to  directly  investigate 
whether GTPases are involved in nuclear protein import. We 
found that nonhydrolyzable analogues of GTP, which often 
are potent inhibitors of GTPase function (Nuoffer and Balch, 
1993),  strongly inhibit nuclear protein import in vitro. We 
determined that the major component sensitive to nucleotide 
inhibition is Ran/TC4, a previously identified member of the 
Ras superfamily of GTP-binding proteins present in both nu- 
cleus and cytoplasm (Drivas et al., 1990; Bischoff and Pon- 
stingl, 1991a; Ren et al.,  1993).  In addition, we found that 
Ran/TC4 is a cytosolic factor required for efficient nuclear 
import.  Ran/TC4  and a  protein  called RCC1,  which is  a 
GNRP for Ran/TC4 (Bischoff and Ponstingl,  1991b), have 
been previously implicated in a  diverse range of nuclear 
functions, including DNA replication, cell cycle feedback 
control,  and  RNA  processing  and  export  (reviewed  by 
Dasso,  1993).  Our results suggest that Ran/TC4 serves to 
integrate nucleocytoplasmic trafficking with these other nu- 
clear functions. 
Materials and Methods 
Cells and Reagents 
Suspension cultures of human (HeLa) cells were grown in Joldik's-modified 
minimal essential medium (GIBCO-BRL,  Gaithersburg, MD) with 10% 
FCS (Hyclone Laboratories, Logan, UT). Nucleotides and nucleotide ana- 
logs  were  obtained  from  Boehringer-Mannheim  Biochemicals  (Indi- 
anapolis, IN). Nucleotide stock solutions (with equimolar Mg-acetate in 50 
mM Hepes, pH 7.5)  were atiquoted,  stored in liquid nitrogen and used 
within 4 wk. Digitonin (high purity), creatine phosphate and creatine phos- 
phokinase were obtained  from Calbiochem-Behring Corp.  (San  Diego, 
CA). A  10% stock solution of digitonin in DMSO was stored in aliquots 
at -20°C. Stocks (10 mg/ml) of Avidin (Canadien Lysozyme, Abbotsford, 
Canada) and Biocytin (Sigma Immunochemicals, St. Louis, MO) were kept 
at 4°C.  Purified ADP-ribosylation factor (ARF)  from bovine brain was 
the generous gift of Dr.  Frank Peter (The Scripps Research Institute, La 
Jolla, CA). 
Preparation of Transport Substrate 
Synthetic peptides containing the SV-40  large T  antigen wild-type NLS 
(CGGGPKKKRKVED) or  a  transport deficient "reverse" NLS  peptide 
(CGGGDEVKRKKKP) were obtained from the Core Facility of TSRI and 
further purified by HPLC. Biotinylated BSA (B-BSA; Pierce Chemical Co., 
Rockford, IL) was activated with Sulfo-SMCC (Pierce Chemical Co.) and 
mixed with a 50-fold excess of peptide. After overnight incubation at 4"C 
the B-BSA-peptide conjugate was separated from free peptide using a PD10 
column (Pharmacia Biotech Inc., Piscataway,  NJ) and subsequent dialysis 
(25-kD molecular weight cut-off). The concentration of the conjugate was 
determined by absorbance at 280 nm. Aliquots were stored at -80°C. The 
number of  peptides conjugated to the protein was estimated by mobility shift 
on SDS-polyacrylamide gels to be ~5-15 peptides per B-BSA molecule. 
Preparation of  HeLa Cell Cytosol 
Exponentially growing cultures of HeLa cells were collected by centrifuga- 
tion at 250 g for 10 rain and washed twice with ice cold PBS by resuspension 
and centrifugation. The cells were then washed with 10 mM Hepes, pH 7.3, 
110 mM potassium acetate, 2 mM magnesium acetate, and 2 mM DTT. The 
cell pellet was resuspended in 1 vol of lysis buffer (5 mM Hepes, pH 7.3, 
10 mM potassium acetate, 2 mM magnesium acetate, 2 mM DTT, 0.1 mM 
PMSE and 1 ttg/ml each of aprotinin, leupeptin, and pepstatin, and swelled 
for 10 min on ice. The cells were then lysed by five strokes in a tight fitting 
stainless steel dounce homogenizer. The resulting homogenates were cen- 
trifuged at 1,500 g for 15 min to remove nuclei and cell debris. The superna- 
tant was then sequentially centrifuged at 15,000 g for 20 min and 100,000 g 
for 30 min. The final supernatant was dialyzed for 3-4 h with a collodion 
membrane  apparatus  (molecular  weight  cut-of  10  kD;  Schleicher  & 
Schuell, Inc., Keene, NH) against transport buffer (20 mM Hepes pH 7.3, 
110 mM potassium acetate, 2 mM magnesium acetate, 0.5 mM EGTA, 
2 mM DTT,  and 1 /~g/ml of aprotinin, leupeptin, and pepstatin) with 0.1 
mM  PMSF  and  frozen in  aliquots  in  liquid  nitrogen before storage at 
-80°C. The protein concentration of the cytosol was 10-12 mg/ml as deter- 
mined by Bio-Rad protein assay (Bio-Rad Laboratories, Richmond, CA). 
Preparation of  ELISA Plates 
Rabbit anti-BSA antibody preparations were obtained from Calbiochem- 
Behring Corp.  and IgGs were purified by chromatography on protein G 
Sepharose. A  solution of 4/zg/mi IgG in 50 mM Na2HCO3,  pH 9.6 was 
plated  onto  immunomodule  strips  (Nunc  Maxisorb  F8  microwell  im- 
munomodules; Thomas Scientific, Swedesboro, N J). Plates were incubated 
for 3 h at 37°C or overnight at 4°C, washed three times in PBS, and then 
incubated in blocking buffer (0.05 % Tween 20 and 0.05 % Gelatin in PBS) 
The Journal  of Cell Biology,  Volume 123, 1993  1650 for 1 h at 37°C. Plates were stored in blocking buffer at 4°C and used within 
2 wk. Immediately before using, the strips were washed three times in PBS. 
Quantitative In Vitro Transport Assay 
Cell Permeabilization.  HeLa suspension cells were harvested by centrifu- 
gation, washed once in transport buffer and resuspended to a density of 0.5 
x  l07 cells/ml. Digitonin was added to a  final concentration of 0.008% 
and the cells were allowed to permeabilize for 7 min on ice. The suspension 
was diluted 10-fold with transport buffer, the cells were harvested and finally 
resuspended in the desired volume (normally 2-8  x  105 cells/10 #l). 
In Vitro Transport.  Transport mixtures (final volume 40/~l) contained 
cytosol  (usually 2-5  mg/ml), an ATP-regenerating system (1  mM ATE 
5 mM creatine phosphate, 20 U/ml creatine phosphokinase), transport sub- 
strate (100 nM biotinylated BSA-peptide), and permeabilized cells (2-8  x 
l05 cells) in transport buffer. The samples were mixed on ice in wells of 
Nunc microwell immunomodules, medium binding (Thomas Scientific). 
The transport reaction was started by transfer into a 30°C water bath and 
stopped, normally after 30 min, by dilution with 200/.tl of ice cold transport 
buffer and transfer of plates to ice. All experiments were carried out in tripli- 
cate to allow accurate quantitation. 
Wash and Lysis Conditions. To remove and block remaining extranuclear 
transport substrate, the wells were spun for 5 min at 300 rpm in a Beckmann 
J6-B centrifuge, 200 #l  of the supernatant were removed and  100 #l of 
avidin in transport buffer (0.1 mg/ml) was added to the cells. After 30 min 
at 4°C,  100 ~l biocytin in transport buffer (0.2 mg/ml) was added and the 
samples were allowed to sit for another  15 min. The samples were cen- 
trifuged again, 200/zl supernatant were removed, and 200 #l of lysis buffer 
(1.0%  Triton  X-100  in  PBS)  was  added.  The  cells  were  thoroughly 
resuspended and allowed to lyse for at least 2 h or overnight at 4°C. 
ELISA-based Detection of Unblocked Transport Ligand. 5/~1 of the cell 
lysate were added to 200/.d of Triton buffer (0.2 % Triton X-100 and 0.05 % 
Gelatin in PBS)  in immunomodule strips previously coated  with  rabbit 
anti-BSA antibodies. After incubation for 3 h at 37°C or overnight at 4°C, 
strips were washed three times with PBS,  incubated for 5  rain in Triton 
buffer and washed three times in PBS (this is referred to as a wash cycle). 
To each well 200 ~1 of streptavidin-HRP (Boehringer-Mannheim Biochemi- 
cal), diluted 1:5,000 in blocking buffer was then added. After 1 h at room 
temperature the strips were washed as before. 200 #1 substrate solution (10 
mg o-phenylenediamine, 10/~1 H202 in 25 ml of 50 mM Na2HPO4, 27 mM 
citrate, pH 5) was added to each well and the incubation allowed to proceed 
until sufficient color was developed, typically 1-3 min. The reaction was 
terminated by addition of 50 ~tl per well of 2 M H2SO4. The A,,90 was read 
on an ELISA plate reader (Bio-Rad Laboratories) and corrected  for the 
A655. Standard curves with transport substrate (0.1-4.0 ng per well) were 
carried out in parallel to allow for conversion of A49o to ng of transported 
ligand. 
Test  for Nuclear Integrity 
Standard transport reactions were set up in either the presence or absence 
of 200 #M GTP'yS. FITC-Dextran (9,400 or 148,900 D, both from Sigma 
Immunochemicals) was added to a final concentration of 0.5 mg/ml 15 min 
after the start of the reaction. After another 15 min the cells were mounted 
onto coverslips and immediately photographed using a Zeiss Axiophot mi- 
croscope and Kodak TMAX400 films. To visualize transport by fluores- 
cence microscopy in this experiment,  we  used allophycocyanin coupled 
with NLS peptides as the transport ligand (Adam et al.,  1990). 
Fractionation of Cytosol 
Aliquots of cytosol were thawed and spun at 100,000 g for 10 min. The su- 
pernatant was then concentrated twofold using centricon-10 concentrators 
(Amicon Corp., Beverly, MA). 200 #1 of this cytosol were applied to a Su- 
perose 12 column connected to an FPLC system (Pharmacia) and 1-nil frac- 
tions were collected. Each fraction was concentrated to 100/~1 using again 
centricon-10 concentrators. 
Expression and Purification of  Ran/TC4 
A clone containing a eDNA for human Ran/TC4 was kindly provided by 
Dr. Peter D'Eustachio (New York University Medical School, New York). 
The coding region was amplified by PCR using primers that introduced two 
unique restriction sites at the termini, an NcoI site at the start codon and 
a BamHI site 5 bp after the stop codon. The fragment was ligated into the 
vector pETlld  which was then transformed into Escherichia coil BL21- 
(DE3). To obtain protein expression, transformed bacteria, freshly grown 
to an OD595 =  0.6' were supplied with 1 mM IPTG and allowed to grow 
for 4  h at 37°C. The cells were harvested by centrifugation, resuspended 
in l0 mM Tris/HCl pH 8.0,  10%  sucrose, 0.1 mM PMSE  1/~g/ml each of 
aprotinin, leupeptin, and pepstatin (5 ml buffer/50 ml culture) and frozen 
in liquid nitrogen. After thawing lysozyme was added to 1 mg/ml and the 
suspension was incubated for 40 min on ice, and then 1 mM MgC12 and 
1 mM DTT were added. Soluble proteins obtained by centrifugation of cell 
lysates at 60,000 rpm in a Beckman TLA100.3 rotor for 40 min were applied 
to a DEAE-Sepharose column previously equilibrated in 10 mM Tris/HC1, 
pH 8.0,  1 mM MgC12,  1 mM DTT, 0.1 mM PMSE  1 #g/ml each of aproti- 
nin, leupeptin, and pepstatin. The flow through and wash were discarded 
and Ran/TC4 was eluted with  100 mM NaCl.  Fractions containing Ran/ 
TC4 were pooled,  concentrated,  and applied onto a  Superose  12 FPLC 
column equilibrated with transport buffer. Fractions containing Ran/TC4 
were pooled and used either freshly or after storage at  -80°C.  The Ran/ 
TC4 obtained by this procedure was ~80% pure. To account for effects of 
the contaminating proteins a control sample was obtained by carrying out 
the identical induction, lysis, and fractionation procedure with cells con- 
taining the vector pETlld only. 
Gel Electrophoresis and lmmunoblotting 
SDS-PAGE  was  carried  out  as  described  previously  (Adam  and  Ger- 
ace,  1991).  Detection of Ran/TC4 on immunoblots was performed as de- 
scribed (Ren et al.,  1993)  using antibodies kindly provided by Dr.  Peter 
D'Eustachio. 
Results 
An Improved Assay for Quantitative Analysis of  In 
Vitro Nuclear Import 
We adapted the in vitro assay for nuclear protein import de- 
veloped by Adam et al.  (1990) to include an ELISA-based 
detection system to allow rapid quantitative analysis of a 
large number of samples (see Materials and Methods). The 
transport ligand in this assay was B-BSA conjugated with 
synthetic NLS peptides.  This new assay fulfills numerous 
criteria for physiologically relevant nuclear import. Trans- 
port depends on the presence of cytosol (Fig. 1 A), saturating 
at a cytosolic protein concentration of 2-3 mg/ml, and is de- 
pendent on temperature and ATP (Fig.  1 C). Furthermore, 
transport requires the presence of a wild-type NLS (CGG- 
GPKKKRKVED) on  B-BSA,  as  B-BSA  alone gave only 
backround signal and B-BSA conjugated with a transport- 
deficient reverse NLS peptide (CGGGDEVKRKKKP; Adam 
et al.,  1989) gave a very low signal (Fig.  1 C). 
The accumulation of B-BSA-NLS in the nucleus is linear 
over at least 25 min. A representative experiment is shown 
in Fig.  1 B, where 45 ng of ligand were transported during 
25 rain in an assay containing 6  x  105 cells. This is equiva- 
lent to  roughly 6.6  ×  1@  molecules per  cell.  Assuming 
there are 2  x  103 active NPCs per nucleus (Gerace, 1992), 
this would reflect an average rate of about 1 molecule per 
NPC per 4 s. This in vitro transport rate obtained with our 
standard subsaturating concentration of ligand is in the same 
range as rates determined for in vivo nuclear import in Xeno- 
pus oocytes (Goldfarb et al.,  1986). 
Nonhydrolyzable Analogues of GTP Specifically Inhibit 
Nuclear Protein Import 
We found that addition of nonhydrolyzable GTP analogues 
to our in vitro nuclear import system resulted in virtually 
complete inhibition of transport under standard cytosol and 
cell concentrations (see below). The three analogues that we 
tested, GMP-PNE GMP-PCP, and GTP~/S were all effective 
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Figure  1.  Characterization of an improved assay for quantitative 
analysis of in vitro nuclear import. Transport assays and measure- 
ment of transported ligand using an ELISA method were carried 
out as described in Materials  and Methods.  Each point represents 
the average of triplicate transport assays and error bars represent 
standard deviations.  (A) Cytosol dependence of transport. The ac- 
cumulation of biotinylated BSA-NLS (B-BSA-NLS) in the nucleus 
as a function  of cytosol concentration  in the reaction mix was deter- 
mined after incubation of 4  x  105 cells per assay for 30 min at 
30°C. (B) Time course of transport. In vitro transport was carried 
out for the indicated  times with 6  x  105 cells per assay and 2.5 
mg/ml cytosol.  (C) Dependence of transport on ATP, temperature 
and nuclear localization sequence.  All reactions  were carried out 
for 30 min with 2.5 mg/ml cytosol and 4  x  105 cells.  (Standard) 
30°C,  B-BSA-NLS as transport ligand.  (-ATP) addition of 0.1  U 
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Figure 2.  Nonhydrolyzable analogues of GTP inhibit nuclear pro- 
tein import. Transport was carried out in the presence of varying 
amounts of GTP analogues  for 30 min with 3  x  105 cells in the 
presence  of  an  ATP  regenerating  system  (see  Materials  and 
Methods).  (A) Inhibition with GTP3,S was measured in the pres- 
ence or absence of 1 mM GTP in the transport mixture. The nucleo- 
tides were added to the complete transport mixture on ice immedi- 
ately before the reaction was started.  The final concentrations of 
GTP3,S in the reaction are indicated.  (B)  The effect of varying 
amounts of the GTP analogues GMP-PNP and GMP-PCP in the as- 
say were tested.  The inhibitors were added to the complete trans- 
port mixture on ice immediately before the reaction was started. 
The difference in the total amount of protein transported  in A vs. 
B is due to different ligand preparations  used in the two assays. 
in transport inhibition (Fig. 2). This inhibition was specific 
for guanine nucleotides, as it occurred in the presence of ex- 
cess ATP (1 mM) but was diminished with an excess of GTP. 
As shown in Fig. 2 A, half-maximal inhibition  was achieved 
with approximately 10/~M GTPTS in the absence of GTP 
or with 80/~M GTP3,S in the presence of 1 mM GTP. With 
the other inhibitors, half maximal inhibition was achieved 
with somewhat higher concentrations, corresponding to ap- 
hexokinase/5  mM glucose before  start  of the standard reaction. 
(0°C) 30 min at 0°C with standard ligand. (Reverse) B-BSA cou- 
pled to "reverse" NLS peptides as transport ligand under standard 
conditions.  (B-BSA)  Biotinylated  BSA as transport ligand under 
standard  conditions. 
The Journal  of Cell  Biology,  Volume  123,  1993  1652 Figure 3.  GTP3,S does not affect nuclear integrity. Transport reactions were carried out in the presence or absence of 200 pM GTP-yS 
for 30 min using 2  x  llY cells per assay and 2.5 mg/ml cytosol. The cells were then mounted onto coverslips without washing and pho- 
tographed directly using epifluorescence (left micrograph of each pair) or phase contrast (right micrograph of each pair) optics. (A) AI- 
lophycocyanin coupled to NLS-containing peptides was used as the transport ligand. (B) After 15 min of transport (using B-BSA-NLS 
as the transport ligand) 0.5 mg/ml fluorescein-dextran with a molecular weights of 9,400 D was added to the reaction. (C) After 15 min 
of transport (using B-BSA-NLS as the transport ligand) 0.5 mg/ml fluorescein-dextran with a molecular weight of 149,000 D was added 
to the reaction. 
proximately 100/~M GMP-PNP or 100 #M GMP-PCP (Fig. 
2  B).  The  observation that  all  three analogues  inhibited 
transport argues against the possibility that thiophosphoryla- 
tion of ATP led to transport inhibition.  Instead these data 
suggest that hydrolysis of GTP is involved in nuclear protein 
import. 
The inhibitory effect  of  GTP~/S on nuclear import was also 
evident when a fluorescent ligand (allophycocyanin coupled 
with synthetic NLS peptides; Adam et al.,  1990) was used 
to monitor transport. Addition of 200 #M GTP3,S to the as- 
say greatly reduced nuclear ligand accumulation compared 
to a control sample (Fig 3 A). Interestingly, in the presence 
of nonhydrolyzable GTP analogues we never observed ac- 
cumulation of fluorescent ligand in a rimlike pattern at the 
nuclear periphery, which is indicative of ligands docked at 
the NPC (Newmeyer and Forbes,  1988; Richardson et al., 
•988).  If GTP hydrolysis were required only at a transport 
step distal  to docking, one would expect accumulation of 
ligand in a docked configuration in the presence of GTP'rS. 
In other experiments, we investigated the effects of GTP-/S 
on docking by carrying out nuclear import assays at 30°C un- 
der conditions of ATP depletion (Newmeyer and  Forbes, 
1988; Richardson et al.,  1988), wherein docked ligands ac- 
cumulate at the cytoplasmic surface of the NPC (Newmeyer 
and Forbes, 1988; Richardson et al., 1988). In this case, we 
found that GTP'yS strongly inhibited the rate of accumula- 
tion of ligands at the nuclear periphery (data not shown), 
supporting the notion that GTP hydrolysis is required at a 
transport step prior to or involving ligand docking at the 
NPC. 
To test whether the effects of GTP~/S are trivially due to 
disruption  of nuclear  integrity or  wholesale occlusion of 
NPCs,  we carded out transport in the presence of GTP3,S 
and one of two different fluorescent dextrans (Figs. 3, B and 
C). An •10-kD  dextran, which is small enough to readily 
diffuse  into  the  nucleus  in  vivo,  was  used  to  measure 
diffusional permeability of the NPC, and an '~150-kD dex- 
tran, which is too large to diffuse into an intact nucleus in 
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Figure 4.  Inhibition by GTP'yS is dependent on concentrations of 
permeabilized cells and cytosol.  The effect of 200/zM GTP'yS on 
in vitro transport was measured as a function of cytosol concentra- 
tion for  1.5  x  ]05 cells (A) or for 6  x  1@ cells (B) per 40-/d 
transport reaction. Transport and determination of the amount of 
ligand transported  per assay were otherwise  carried  out  as de- 
scribed in Materials and Methods. As the degree of inhibition ob- 
tained by GTP3,S varied with the batch of cytosol and also with the 
preparation ofdigitonin permeabilized cells, the experiments in this 
figure were done in parallel using the same materials for A and B. 
vivo, was used to measure nuclear intactness (Paine et al., 
1975; Peters, 1986). As shown in Fig. 3 B, the low molecular 
weight dextran accumulated in nuclei of the GTP3,S-treated 
sample  similar to  the  control  sample,  indicating  that the 
diffusional channel of the NPC is not detectably occluded. 
The  150-kD dextran was excluded from nuclei whether or 
not GTPTS was present (Fig.  3 C), indicating that the nu- 
clear envelope does not become disrupted by the nucleotide 
analogue. A separate approach also led to the conclusion that 
the inhibitor did not compromise nuclear integrity: transport 
was initially carried out in the absence of inhibitor and at 
different time points  up  to  30  min  100  #M  GTP3~S was 
added. The transport reaction was then continued for the re- 
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Figure 5.  GTP3,S affects the rate of nuclear  protein  import.  Ac- 
cumulation of ligand over time was measured in the presence or ab- 
sence of 200  #M GTP3,S. 2.5  mg/ml cytosol and 6  ×  1@ cells 
were used per assay. The transport  was stopped at the indicated 
times and processed as described in Materials and Methods. In the 
experiment  shown, 6  ×  105 cells led to 70% inhibition,  while in 
a similar experiment conducted with a different batch of cytosol the 
same degree  of inhibition and the  same shape of the curve was 
achieved with 3  ×  105 cells (data not shown). 
mainder of the 30 min, before the samples were processed 
to measure nuclear accumulation of ligand. This experiment 
showed that ligand which had accumulated in the nuclei at 
the time of GTP3~S addition remained in the nucleus during 
the subsequent incubation with GTP3,S  (data not shown). 
We conclude from these data that GTP~,S does not affect nu- 
clear integrity nor does it detectably block the diffusional 
channel of the NPC. 
Transport Inhibition Is Dependent on Concentrations 
of Cells and Cytosol 
The inhibitory  effects of GTP'yS on  nuclear  import were 
strongly influenced by both cell and cytosol concentrations 
in the assay (Fig. 4). While low cell concentrations yielded 
almost complete transport inhibition  with  GTP'yS, higher 
cell concentrations resulted in markedly reduced or no trans- 
port inhibition. As shown in Fig. 4 A, when 1.5  x  105 cells 
per 40-/zl reaction was analyzed, GTP3,S yielded virtually 
complete transport inhibition over a broad range of cytosol 
concentrations.  By contrast,  essentially  no inhibition  was 
obtained  with  6  x  I@  cells  per 40-#1  reaction  up  to  a 
cytosol concentration of 5 mg/ml. However, further increas- 
ing the cytosol concentration in this sample again resulted 
in  transport  inhibition.  An  intermediate  concentration  of 
cells in the assay (3  x  105 cell per 40-/~1 reaction) yielded 
a level of inhibition intermediate between that obtained with 
1.5  x  1@ cells and 6  x  105 cells (data not shown; see also 
Fig.  5).  Hence, depending on the concentration of cytosol 
and cells in the assay, the inhibition can vary from 0 to 95 %. 
This phenomenon was observed with all cytosol and perme- 
abilized cell preparations tested, although it should be empha- 
sized  that  the  concentration  of  cells  required  to  obtain 
specific degrees of transport inhibition varied with different 
cytosols as well as with different permeabilized cell prepara- 
tions.  We  presently  have  no  clear  understanding  of this 
effect,  which  could  involve complex interactions  between 
nuclear and cytoplasmic pools of GTP-binding proteins and 
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their regulators.  Nevertheless, this observation was crucial 
for identifying the transport factor sensitive to GTP~S (see 
below). 
Fig. 5 shows the kinetics of ligand accumulation in the nu- 
cleus in the presence or absence of GTP'yS under conditions 
which lead to 70% inhibition at 30 min. The transport rate 
was linear throughout the time course both in the presence 
or absence of GTP3~S, but the rate of transport was strongly 
reduced in the presence of inhibitor. It is important to note 
that 70 % inhibition was already seen during the first 5 min 
of the reaction, so there is no apparent lag in the effects of 
the inhibitor. Hence, GTP3~S continuously affects the rate of 
transport throughout the time course of this assay in a cytosol 
and permeabilized cell concentration-dependent fashion. 
A Low Molecular Weight Cytosolic Fraction Is 
Responsible  for GTP~S-Mediated  Inhibition and Is 
Required  for Transport 
As  an approach to characterizing  the  transport factor in- 
hibited by GTP3,S, we examined whether inhibition could be 
stably maintained after a brief exposure of transport compo- 
nents to the GTP analogue. We preincubated either perme- 
abilized cells or cytosol or a combination of both with GTPTS 
at 30°C, added an excess of GTP to compete with the inhibi- 
tor  (see  Fig.  2  A),  and  then  compared transport  in  the 
pretreated fraction with untreated counterparts. However, no 
irreversible inhibition  was  achieved under  any  conditions 
tested (data not shown), indicating that GTP3,S must be pres- 
ent in the assay throughout the transport incubation to exert 
inhibitory effects. We therefore explored a second approach 
for characterizing the GTP3,S sensitive factor. 
Since a high concentration of cytosol can substantially in- 
crease the level of transport inhibition by GTP3,S in an assay 
containing a relatively high cell concentration (Fig. 4 B), we 
reasoned that cytosol contains a factor responsible for medi- 
ating  or enhancing  GTP3,S  inhibition  in  a  concentration- 
dependent  manner.  To  identify  this  factor,  we  resolved 
cytosol into 13 fractions by molecular sieving chromatogra- 
phy, concentrated each fraction fourfold (relative to the ini- 
tial cytosol) and individually added the fractions to transport 
mixtures containing complete cytosol in the absence or pres- 
ence of GTP3,S (Fig. 6). The concentration ofpermeabilized 
cells in the transport incubation was adjusted to yield about 
50% transport inhibition in the presence of GTP3,S without 
added cytosolic fractions (Fig. 6 A, leftmost bars). Addition 
of most  cytosol  fractions  to  the  transport  assay  had  no 
significant effect, either on the transport rate without GTP-yS 
or on the degree of inhibition obtained with GTP3~S. A few 
fractions enhanced  (e.g.,  fraction  8)  or diminished  (e.g., 
fraction  6)  the  basal  level  of transport  in  the  absence  of 
GTP3,S, but the relative degree of inhibition in the presence 
of GTP3,S was similar to the control. A  strikingly different 
result was obtained with fraction 9, which corresponds to the 
peak of 20-30-kD globular proteins (arrow in Fig. 6). Addi- 
tion of concentrated fraction 9 did not significantly influence 
the level of transport in the absence of inhibitor, yet dramati- 
cally increased the degree of transport inhibition obtained 
with GTP~S to >90%. The ability of fraction 9 to strongly 
enhance  the  inhibitory  effect of GTP3,S  on transport was 
highly reproducible. For example, Fig. 6 B presents a sepa- 
rate  experiment  with  a  different  batch  of  fractionated 
cytosol.  To determine whether this low molecular weight 
fraction  was also required  for transport,  we pooled  frac- 
tions  1-8  +  10-12 and tested the transport activity of this 
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pressed Ran/TC4 is the major 
component of  the low molecu- 
lar  weight fraction  required 
for nuclear import and inhibi- 
tion by GTP3,S. Ran/TC4 was 
expressed  in  E.  coli  as  de- 
scribed  in  Materials  and 
Methods and was enriched by 
ion exchange chromatography 
and  molecular  sieving on  a 
Superose 12 column. To con- 
trol  for  impurities,  a  mock 
preparation was done in paral- 
lel from E. coli  containing the 
expression vector only with- 
out  the  Ran/TC4 insert.  (A) 
Superose fractions of cytosol 
were obtained as described in 
Fig.  6.  Fractions  1-8  + 
10-12  were  tested  either 
alone  (buffer)  or  supple- 
mented with 10-#1 fraction 9 
(+fr.9),  7  #1  purified  Ran/ 
TC4  (Ran) or  7  #1  mock- 
purified  Ran/TC4 (control), 
using 3 x  105 cells per assay. 
(B)  Unfractionated  cytosol 
was  tested  alone  (buffer) or 
supplemented with 10-#1 fraction 9 (+fr.9) or 10 #1 purified Ran/TC4 (Ran) in the presence or absence of 200 #M GTP3"S, using 6  x 
1@ cells per assay. (C) SDS-PAGE  of the mock preparation isolated from E. coli (control), the Ran/TC4 preparation (Ran), and fraction 
9 (ft.9). 5 #1 of each sample was applied to the gel, which was stained with Coomassi~ blue. (D) Immunoblot analysis of cytosol fractions 
obtained by molecular sieving on Superose 12 using antibodies against Ran/TC4. (Cytosol) Complete cytosol; (142) 7 #1 of fractions 1-12 
respectively (threefold concentrated over cytosol); (Ran) 7 t~l of the bacterially expressed Ran/TC4. 
pool alone or with added fraction 9 (Fig. 6 C). When frac- 
tion 9 was omitted, the transport activity was greatly dimin- 
ished, demonstrating that some factor(s) in this fraction is 
required for efficient nuclear import. 
The Small GTPase Ran/TC4 Is a 
GTP,  tS-Sensitive Transport Factor Involved 
in Nuclear Protein Import 
The data above provided evidence for a 20-30-kD cytosolic 
protein which was required for nuclear protein import and 
which enhanced inhibitory effects of  GTP3,S. It seemed plau- 
sible that this component itself  was a GTPase, since GTPases 
are of widespread importance as cellular regulators and are 
often  strongly  inhibited  by  GTPqrS.  Furthermore,  many 
GTPases occur in this molecular weight range, most notably, 
GTPases of the Ras superfamily (Bourne et al.,  1991). Two 
small  GTPases  have  been  previously  suggested  to  have 
potential  roles  in  nuclear  function,  the  25-kD  protein 
Ran/TC4 and the 20-kD protein ARF (ADP ribosylation fac- 
tor). Ran/TC4 appears to be directly or indirectly involved 
in a large number of nuclear functions including DNA repli- 
cation, cell cycle feedback control, and RNA synthesis, pro- 
cessing and export (Dasso,  1993). ARF has been shown to 
be responsible for inhibition of in vitro nuclear reassembly 
in the presence of GTP3,S (Boman et al., 1992), and also has 
an extensively characterized role in vesicle budding along 
the  secretory pathway  (Pfeffer,  1992;  Nuoffer and  Balch, 
1993). 
We therefore examined whether either of these two pro- 
teins was the component of fraction 9 required for nuclear 
import. Purified ARF from bovine brain, which was active 
in an ER to Golgi membrane transport assay (Nuoffer and 
Balch, 1993), had no effect when added to an assay contain- 
ing a pool of all cytosol fractions except fraction 9 (data not 
shown).  By contrast,  striking  results  were obtained with 
purified recombinant Ran/TC4. Addition of Ran/TC4 to the 
transport assay lacking fraction 9 increased the level of nu- 
clear transport in this sample to the degree obtained with 
concentrated fraction 9 itself (Fig. 7 A; see also Fig. 6 C). 
This  effect  was  not  due  to  bacterial  impurities  in  the 
Ran/TC4 preparation, since a control sample purified from 
control bacterial lysates and containing all of the minor con- 
taminant bands found in the Ran/TC4 sample (Fig. 7 C, com- 
pare Ran lane to control lane) was without effect. We esti- 
mate that the amount of recombinant Ran/TC4 added to the 
transport assays in Fig. 7 is no more than severalfold greater 
than the amount of endogenous cytosolic Ran based on the 
relative immunoblot signals given by the two samples (Fig. 
7 D). Saturating concentrations of Ran/TC4 were added to the 
samples in Fig. 7 since up to fourfold lower concentrations 
of added Ran yielded the same effect (data not shown). This 
suggests a direct involvement of Ran/TC4 in nuclear import. 
Supporting  this  conclusion,  the chromatographic peak of 
cytosolic Ran/TC4 coincides with fraction 9, as determined 
by immunoblotting with antibodies to Ran/TC4 (Fig. 7 D). 
The residual level of transport in cytosol lacking fraction 9 
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tions 8 and 10 which is not resolved by molecular sieving, 
although we cannot formally exclude the possibility that a 
low level of nuclear import can occur in the absence of cyto- 
solic Ran/TC4. 
In a second experiment, we examined whether Ran/TC4 
was responsible for inhibition by GTPTS in this assay (Fig. 
7 B). Recombinant Ran/TC4 was added to a transport assay 
that was adjusted to give a low level of inhibition by GTP3,S 
in the absence of additions. We found that addition of exoge- 
nous Ran/TC4 to the system yielded virtually the same de- 
gree of transport inhibition as concentrated fraction 9 itself. 
In conclusion, these data directly demonstrate that Ran/TC4 
is a cytosolic factor involved in nuclear import, and that this 
protein is a major factor involved in inhibition of transport 
by GTP~/S. 
Discussion 
We have shown that GTP'yS and other nonhydrolyzable  GTP 
analogues inhibit the rate of nuclear import in permeabilized 
cells.  We  identified  the  GTP-yS-sensitive component  as 
Ran/TC4 and demonstrated that this protein is required for 
efficient nuclear protein import. It is possible that additional 
GTPases besides Ran/TC4 are involved in nuclear import, 
although these are not clearly revealed with our standard 
assay and inhibition conditions. A requirement for Ran/TC4 
in nuclear protein import also was demonstrated with an in 
vitro system involving Xenopus cytosol, indicating a role in 
diverse cell types (Moore and Blobel,  1993). 
Ran/TC4 was first identified in mammalian cells as a mem- 
ber of the Ras superfamily of GTPases having about 25 % 
identity to Ras (Drivas et al.,  1990; Bischoff and Ponstingl, 
1991a).  It also was genetically defined as a multicopy sup- 
pressor of mutations in yeast RCC1 homologues (see below; 
Matsumoto  and  Beach,  1991;  Belhumeur  et  al.,  1993; 
Kadowaki et al.,  1993). Ran/TC4 is concentrated in the nu- 
cleus of mammalian cells based on immunofluorescence mi- 
croscopy, but a smaller cytoplasmic pool is also present and 
is released by permeabilization of cells with digitonin (Ren 
et al.,  1993). The relatively high concentration of Ran/TC4 
in the nucleus is presumably due to its interaction with other 
nuclear components,  since  monomeric Ran/TC4  is  small 
enough to rapidly diffuse into the cytoplasm. Nevertheless 
nuclear Ran/TC4 may be in dynamic equilibrium with the 
cytoplasmic pool, and this equilibrium could be important 
for its functions.  The subcellular distribution of Ran/TC4 
could  help  to  explain  the  variable  inhibitory  effects  of 
GTP'yS related to the concentrations of permeabilized cells 
and cytosol in the transport assay (Fig. 4) assuming the nu- 
clear and cytoplasmic pools are differentially sensitive to 
GTP'yS. Since there are  an estimated  107 copies of Ran/ 
TC4 per mammalian cell (Bischoff and Ponstingl,  1991a), 
recycling of this protein would not be required to drive the 
levels of transport obtained in our assay conditions (<1@ 
molecules per cell),  even if Ran/TC4  is  a  stoichiometric 
component of the transport apparatus (see below). 
Our results on the role of Ran/TC4 in nuclear import are 
intriguing in light of recent work on Ran/TC4 and the protein 
RCC1,  which is a GNRP for Ran/TC4 (Bischoff and Pon- 
stingl,  1991b).  RCC1 was first characterized in the hamster 
cell line tsBN2 (Nishimoto et al.,  1978), which contains a 
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Figure 8. Two possible pathways by which Ran/TC4 can integrate 
nuclear functions. See text for discussion. 
mutant RCC1 protein that is rapidly degraded at the restric- 
tive temperature (Nishitani et al.,  1991).  TsBN2 cells that 
are in S phase at the time of the temperature shift enter mito- 
sis without completing DNA replication (Nishimoto et al., 
1978), leading to the view that RCC1, which is a chromatin 
bound  nuclear protein,  is  part  of the  checkpoint control 
mechanism for preventing entry into mitosis until comple- 
tion  of DNA  replication  (reviewed  by  Dasso,  1993).  A 
homologue of RCC1 with a similar mutant phenotype (piml) 
was identified in a genetic screen in Schizosaccharomyces 
pombe (Matsumoto and Beach, 1991). RCC1 has been linked 
to a large number of additional functions, based on genetic 
and biochemical studies of RCC1 homologues in S. cerevisiae 
and vertebrate cells (Aebi et al.,  1990; Clark et al.,  1991; 
Dasso et al.,  1992; Forrester et al.,  1992; Kadowaki et al., 
1993; Amberg et al.,  1993). These include a role in RNA 
synthesis, processing, and export as well as in DNA replica- 
tion.  Recent functional  studies  indicate that mutations  in 
Ran/TC4 can result in a deficiency in DNA replication (Ren 
et al., 1993), similar to RCC1 mutants. Hence, the Ran/TC4- 
RCC1 system is directly or indirectly associated with a large 
number of processes underlying nuclear function. 
The results on Ran/TC4 described in this study in combi- 
nation with previous work indicate that the Ran/TC4-RCC1 
system can integrate numerous nuclear activities (Fig.  8). 
The functional state of the cell (related to DNA replication 
and possibly other processes)  is  thought to influence the 
GNRP activity of RCC1 and perhaps other GNRPs (Dasso, 
1993),  and  probably  affects  the  activity  of hypothetical 
Ran/TC4-GAPs  as well.  This combination of GNRP and 
GAP  activities  would  determine  the  relative amounts  of 
Ran/TC4-GTP and Ran/TC4-GDP in the cell, and thereby 
the activity of the Ran/TC4 system. We assume that in anal- 
ogy with other GTPases (Bourne et al., 1991) the active form 
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way 1 in Fig. 8), active Ran/TC4 could interact  with only a 
single target in the cell, which would be associated with the 
nuclear import machinery.  As such, Ran/TC4 could serve as 
a stoichiometric regulator of nuclear import (similar to the 
role of EF-Tu in protein synthesis;  Bourne et  al.,  1991). 
When the Ran/TC4 system is relatively inactive, the rate of 
nuclear import would decrease. This could indirectly lead to 
inhibition of DNA replication and defects in cell cycle check- 
point control due to inappropriate  concentrations of regula- 
tory molecules in the nucleus compared to the cytoplasm. 
In a second scenario (pathway 2 in Fig. 8) active Ran/TC4 
could interact with multiple targets in the cell either through 
a signaling system (e.g. a protein kinase) or through multiple 
distinct  effectors.  In  this  fashion  Ran/TC4  could  coor- 
dinately  regulate both  the  nuclear  import machinery  and 
other functional components,  such as the DNA replication 
machinery and the p34  ¢dc2 kinase system. 
The observed effects of the Ran/TC4-RCC1  on RNA ex- 
port could be direct, and Ran/TC4 could affect the nuclear 
export machinery  in  a  fashion  similar to  the  import ma- 
chinery. This is compatible with the notion that at least some 
steps of both nuclear import and export (e.g.,  channel gat- 
ing) are likely to be mechanistically similar (Gerace, 1992). 
Alternatively,  the effects of Ran/TC4-RCC1  on RNA export 
could be a consequence of deficiencies in nuclear import. 
This  possibility  is  consistent  with  the  observation  that 
numerous RNA binding proteins continuously "shuttle" be- 
tween nucleus and cytoplasm (Borer et al., 1989;  Meier and 
Blobel,  1992;  Pinol-Roma and Dreyfuss,  1992).  Trapping 
these shuttling proteins in the cytoplasm due to deficient nu- 
clear import could have  profound effects on nuclear RNA 
metabolism and export. 
By  analogy  with  other  GTPases  (Bourne  et  al.,  1991; 
Nuoffer and Balch, 1993), we predict that the active form of 
Ran/TC4 affecting  nuclear import is the GTP-bound form. 
The inhibitory effects of GTP3'S in our nuclear import assay 
are compatible with either pathway  1 or pathway 2  in Fig. 
8, assuming that the functions of Ran/TC4 require hydrolysis 
of bound GTP. If Ran/TC4 is involved in nuclear import ac- 
cording to pathway 1, GTP hydrolysis  most likely would oc- 
cur at a specific step in transport.  Conversely,  if Ran/TC4 
functions according to pathway 2, then multiple components 
and steps involved in nuclear import could be affected. We 
speculate that a transport  step prior to or involving ligand 
docking at the NPC requires GTP hydrolysis, since ligands 
do not accumulate in a docked configuration at the NE when 
transport  is inhibited by GTPTS (this study) or GMP-PNP 
(Moore and Blobel, 1993). Furthermore,  the rate of accumu- 
lation of fluorescent transport ligands at the NE is strongly 
diminished by GTP'yS under standard docking conditions of 
ATP depletion.  Whether the GTP3,S  sensitive  step proxi- 
mal  to docking  involves  Ran/TC4  or another unidentified 
GTPase remains to be established. 
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